Our Discovery Sciences team is well connected to other laboratory services within Q2 Solutions, enabling you to take optimized leads through our bioanalytical services, including high-throughput ADME, pharmacokinetics (PK) and pharmacodynamics (PD). We also offer preclinical and clinical vaccines lab services, and our Translational Science and Innovation Lab (TSAIL) performs fit-for purpose Validation across a Variety of methodologies, including anatomic and digital pathology, flow cytometry, immunoassays and genomics.
Our bioanalysis services include routine large- and small molecule capabilities:
- Method development
- Method validation
- Analysis of clinical and non-clinical samples
Additional specialty services and platforms include:
- In vitro ADME screening assays
- Discovery/development metabolite identification for regulatory filings
- High-throughput bioanalytical assays
- Liquid chromatography mass spectrometry (LC-MS) to support PK testing
- Ligand-binding assays
- Immunoassay services
- ELISA
- Meso Scale Discovery (MSD)
- Electrochemiluminescence (ECL) assays
- Neutralizing antibody assays and anti-drug assays
- Luminex® sandwich assays
- Ultrasensitive (Simoa®) assays
As a wholly owned subsidiary of IQVIA, Q2 Solutions is also able to help move your candidates into clinical studies when appropriate.
